ASCO 2020 | MI-ONCOSEQ: identifying pathogenic germline variants

Erin F. Cobain, MD, of Rogel Cancer Center, Ann Arbor, MI, USA, discusses unexpected results of MI-ONCOSEQ study which involved next-generation genomic profiling of normal and tumor tissue. Dr Cobain describes a high incidence of pathogenic germline variants found that represent important, therapeutic targets. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).